| Title |
Author |
Type |
Date |
Words |
| Bascom Palmer doses first US patient with X-Linked Retinitis Pigmentosa in Nightstar gene therapy clinical trial. |
|
|
Sep 20, 2018 |
254 |
| Zealand Pharma achieves primary and key secondary endpoints in phase three trial assessing dasiglucagon. |
|
|
Sep 20, 2018 |
189 |
| Zealand Pharma achieves primary and key secondary endpoints in phase three trial assessing dasiglucagon. |
|
|
Sep 20, 2018 |
193 |
| Fasenra Shows Consistent Safety and Sustained Efficacy in Long-Term Phase III BORA Trial in Severe Eosinophilic Asthma. |
|
|
Sep 19, 2018 |
312 |
| DFB Soria Completes a Phase 2 Clinical Trial of Submicron Particle Paclitaxel Anhydrous Ointment for Actinic Keratosis. |
|
|
Sep 19, 2018 |
512 |
| Agenus awarded USD5m in milestone payment for initiation of Phase 1 trial of LAG-3 antibody. |
|
|
Sep 18, 2018 |
148 |
| Zealand Pharma achieves endpoints in Phase 3 trial with dasiglucagon. |
|
|
Sep 18, 2018 |
217 |
| Cannabis stocks in focus after Tilray gets DEA approval to import cannabis drug. |
|
|
Sep 18, 2018 |
553 |
| Oramed wins US FDA clearance for IND application for ORMD-0901 to treat type 2 diabetes. |
|
|
Sep 18, 2018 |
202 |
| Actelion Pharmaceuticals reveals results of first randomised controlled trial in portopulmonary hypertension. |
|
|
Sep 18, 2018 |
145 |
| Agenus awarded USD5m in milestone payment for initiation of Phase 1 trial of LAG-3 antibody. |
|
|
Sep 18, 2018 |
152 |
| Oramed wins US FDA clearance for IND application for ORMD-0901 to treat type 2 diabetes. |
|
|
Sep 18, 2018 |
198 |
| Actelion Pharmaceuticals reveals results of first randomised controlled trial in portopulmonary hypertension. |
|
|
Sep 18, 2018 |
141 |
| Tilray announces U.S. DEA approval to import medical cannabis study drug. |
|
|
Sep 18, 2018 |
223 |
| IMV Inc announces initial data from Phase 2 trial of DPX-Survivac with Keytruda. |
|
|
Sep 18, 2018 |
202 |
| Iterum Therapeutics initiates two Phase 3 clinical trials for sulopenem. |
|
|
Sep 18, 2018 |
112 |
| AstraZeneca's Lumoxiti (moxetumomab pasudotox-tdfk) gains USFDA approval for certain patients with relapsed or refractory hairy cell leukaemia. |
|
|
Sep 17, 2018 |
235 |
| AstraZeneca's Lumoxiti (moxetumomab pasudotox-tdfk) gains USFDA approval for certain patients with relapsed or refractory hairy cell leukaemia. |
|
|
Sep 17, 2018 |
231 |
| Allergan plc announces positive results from clinical study of higher dose of BOTOX Cosmetic in patients with glabellar lines. |
|
Clinical report |
Sep 17, 2018 |
278 |
| Allergan plc announces positive results from clinical study of higher dose of BOTOX Cosmetic in patients with glabellar lines. |
|
Clinical report |
Sep 17, 2018 |
274 |
| Menlo Therapeutics initiates enrollment in second Phase 3 trial of serlopitant. |
|
|
Sep 17, 2018 |
169 |
| Argenx reports Phase 2 proof-of-concept clinical trial of efgartigimod. |
|
|
Sep 17, 2018 |
362 |
| Cro Service For Clinical Trial Effect Of Adjuvant Treatment With N-acetylcysteine. |
|
|
Sep 17, 2018 |
116 |
| Kiniksa presents Phase 1a/1b data for KPL-716 in atopic dermatitis. |
|
|
Sep 15, 2018 |
301 |
| Incyte announces Phase 2b trial of ruxolitinib cream met primary endpoint. |
|
|
Sep 13, 2018 |
372 |
| Spectrum expands poziotinib trial into first-line therapy, doses first patient. |
|
|
Sep 12, 2018 |
321 |
| Natera reports 'several million dollar agreement' for clinical trial. |
|
|
Sep 12, 2018 |
119 |
| Spectrum Pharmaceuticals Expands Poziotinib Clinical Trial into First-Line Therapy and Doses First Patient. |
|
|
Sep 12, 2018 |
413 |
| Atreca Raises USD 125m to Expand its Preclinical Pipeline and Advance its First Program into Clinical Trials. |
|
|
Sep 12, 2018 |
141 |
| Verrica Pharmaceuticals announces results from Phase 2 VP-102 trial. |
|
Financial report |
Sep 12, 2018 |
365 |
| Innovent Biologics treats first patient under phase III clinical trial of sintilimab for non-squamous non-small cell lung cancer (NSCLC). |
|
|
Sep 11, 2018 |
266 |
| Innovent Biologics treats first patient under phase III clinical trial of sintilimab for non-squamous non-small cell lung cancer (NSCLC). |
|
|
Sep 11, 2018 |
262 |
| Merck: Phase 3 clinical study of ZERBAXA met pre-specified primary endpoints. |
|
Clinical report |
Sep 11, 2018 |
158 |
| United States : Early stage clinical trial of antimalarial drug begins. |
|
|
Sep 11, 2018 |
474 |
| Innovent announces CFDA IND approval for Anti-CD47 Antibody IBI188. |
|
|
Sep 10, 2018 |
235 |
| Innovent announces CFDA IND approval for Anti-CD47 Antibody IBI188. |
|
|
Sep 10, 2018 |
231 |
| Five Prime Therapeutics Completes Phase 1 Safety Lead-In and Initiates Phase 3, Global Registrational Trial of Bemarituzumab in Front-Line Advanced Gastric and Gastroesophageal Junction Cancers. |
|
|
Sep 10, 2018 |
581 |
| Amicus: FDA says current package not sufficient for accelerated AT-GAA approval. |
|
|
Sep 10, 2018 |
435 |
| Cyclacel Pharmaceuticals initiates Phase 2 trial of sapacitabine with olaparib. |
|
|
Sep 10, 2018 |
166 |
| Eli Lilly initiates IXORA-R head-to-head clinical trial. |
|
Clinical report |
Sep 10, 2018 |
164 |
| Feasibility Studies To Build Collaborative Partnerships In Cancer Research (p20 Clinical Trial Not Allowed). |
|
|
Sep 9, 2018 |
238 |
| United States : Sangamo Announces 16 Week Clinical Results Including Reductions In Glycosaminoglycans In Phase 1/2 Trial Evaluating SB-913, A Zinc Finger Nuclease Genome Editing Treatment For MPS II (Hunter Syndrome). |
|
Financial report |
Sep 9, 2018 |
675 |
| QLHC reports new randomized, investigational I-SPY 2 TRIAL of olaparib and durvalumab for breast cancers. |
|
|
Sep 7, 2018 |
246 |
| QLHC reports new randomized, investigational I-SPY 2 TRIAL of olaparib and durvalumab for breast cancers. |
|
|
Sep 7, 2018 |
242 |
| Compugen announces first patient dosed with COM701 in Phase 1 clinical trial. |
|
|
Sep 7, 2018 |
139 |
| United States : Athenex Announces Positive Recommendation by the Drug Safety Monitoring Board Upon the Second Interim Analysis and to Continue the Oraxol Phase III Program. |
|
|
Sep 7, 2018 |
334 |
| United States : Pfizer Terminates Domagrozumab (PF-06252616) Clinical Studies for the Treatment of Duchenne Muscular Dystrophy. |
|
Clinical report |
Sep 6, 2018 |
347 |
| United States : Life Sciences Companies Move to Veeva Vault CTMS for Greater Visibility and Speed in Clinical Trials. |
|
|
Sep 6, 2018 |
456 |
| United States : Clinical trial testing topical cream plus influenza vaccine in progress. |
|
|
Sep 6, 2018 |
461 |
| Kineta Launches First-in-Human Clinical Trial of LHF-535 for Lassa Fever. |
|
|
Sep 6, 2018 |
314 |
| argenx doses first patient in global Phase 3 registration trial of efgartigimod for gMG. |
|
|
Sep 6, 2018 |
177 |
| Redx receives UK support to re-start phase 1/2a clinical study for RXC004. |
|
Clinical report |
Sep 6, 2018 |
153 |
| argenx doses first patient in global Phase 3 registration trial of efgartigimod for gMG. |
|
|
Sep 6, 2018 |
173 |
| Redx receives UK support to re-start phase 1/2a clinical study for RXC004. |
|
Clinical report |
Sep 6, 2018 |
149 |
| Verastem doses first patient in Phase 1/2 trial of cancer combination candidate. |
|
|
Sep 6, 2018 |
126 |
| Synthetic Biologics, Cedars-Sinai enter agreement for clinical study of SYN-010. |
|
|
Sep 6, 2018 |
310 |
| Replimune gets FDA acceptance of IND application for RP1. |
|
|
Sep 6, 2018 |
263 |
| Eurofins completes acquisition of Clinical Research Laboratories in North America. |
|
|
Sep 5, 2018 |
203 |
| CytoSorbents' REFRESH 2-AKI Protocol revisions wins US FDA's approval. |
|
|
Sep 5, 2018 |
220 |
| CytoSorbents' REFRESH 2-AKI Protocol revisions wins US FDA's approval. |
|
|
Sep 5, 2018 |
216 |
| ProQR Therapeutics announces interim results from QR-110 clinical trial. |
|
Financial report |
Sep 5, 2018 |
119 |
| Histogenics' NoeCart did not meet primary endpoint of Phase 3 trial. |
|
|
Sep 5, 2018 |
260 |
| RA Pharmaceuticals completes Phase 2 FDA interactions, designs Phase 3 program. |
|
|
Sep 5, 2018 |
194 |
| Tyme Technologies exceeds enrollment expectations for Phase 2 SM-88 trial. |
|
|
Sep 5, 2018 |
144 |
| BioCardia announces additional data from Phase III CardiAmp heart failure trial. |
|
|
Sep 5, 2018 |
161 |
| Celsion reaches enrollment for Phase 3 OPTIMA study. |
|
Clinical report |
Sep 5, 2018 |
117 |
| Neurotrope, Nemours collaborate to initiate clinical trial in Fragile X syndrome. |
|
|
Sep 5, 2018 |
270 |
| JAMA publishes Phase III study using 22nd Century's SPECTRUM cigarettes. |
|
Clinical report |
Sep 5, 2018 |
317 |
| Mati Therapeutics Interim Phase II Nepafenac Clinical Trial Results Signal Significant Post-op Pain Reduction in Cataract Surgery Patients. |
|
|
Sep 5, 2018 |
343 |
| Inovio reports first patient dosed in hepatitis C vaccine Phase 1 study. |
|
|
Sep 4, 2018 |
179 |
| Pieris announces dosing of first patient in Phase 1 combination trial. |
|
|
Sep 4, 2018 |
209 |
| Opko Health initiates Phase 2 trial of Rayaldee. |
|
|
Sep 4, 2018 |
163 |
| Arrowhead Completes Dosing in Phase 1 Study of ARO-AAT for Treatment of Alpha-1 Liver Disease. |
|
|
Sep 4, 2018 |
282 |
| Nextism reveals results of supplementary Phase III E-FIT trial. |
|
|
Sep 3, 2018 |
238 |
| Pfizer to halt two trials for treatment of Duchenne muscular dystrophy. |
|
|
Sep 3, 2018 |
154 |
| Nextism reveals results of supplementary Phase III E-FIT trial. |
|
|
Sep 3, 2018 |
234 |
| Pfizer to halt two trials for treatment of Duchenne muscular dystrophy. |
|
|
Sep 3, 2018 |
150 |
| Positive Interim Safety Data In Phase 3 ALS Trial. |
|
Clinical report |
Sep 3, 2018 |
201 |
| Preliminary Results From Phase 3 Heart Failure Trial. |
|
|
Sep 3, 2018 |
648 |
| Stem Cell Therapy Meets Safety, Efficacy Endpoints In GvHD Trial. |
|
|
Sep 3, 2018 |
424 |
| Positive Interim Safety Data In Phase 3 ALS Trial. |
|
Clinical report |
Sep 3, 2018 |
201 |
| Preliminary Results From Phase 3 Heart Failure Trial. |
|
|
Sep 3, 2018 |
648 |
| Stem Cell Therapy Meets Safety, Efficacy Endpoints In GvHD Trial. |
|
|
Sep 3, 2018 |
424 |
| Testing for Sudbury--made cancer tool begins: RNA Diagnostics, Inc. announces clinical trial for breast cancer monitoring tool. |
McKinley, Karen |
|
Sep 1, 2018 |
1023 |
| Risk factors for hepatitis C: A clinical study. |
Gupta, Sonu; Sodhi, Surender; Brar, Gursimrat; Bansal, Ravinder |
Clinical report |
Sep 1, 2018 |
4313 |
| Clinical Trial Finds Telos95 Supports Cellular Health. |
|
|
Sep 1, 2018 |
247 |
| Gender Differences in Heart Disease: Some risk factors are unique to females, and women are less likely to be studied in clinical trials. |
|
|
Sep 1, 2018 |
701 |
| AstraZeneca updates on TULIP 1 Phase III trial for anifrolumab. |
|
|
Aug 31, 2018 |
251 |
| AstraZeneca updates on TULIP 1 Phase III trial for anifrolumab. |
|
|
Aug 31, 2018 |
247 |
| JHL Biotech Receives Positive CHMP Scientific Advice for Global Phase III Clinical Trial of Proposed Bevacizumab Biosimilar to Treat Lung Cancer. |
|
|
Aug 31, 2018 |
476 |
| Singapore's First Clinical Trial Approval for T-cell Engineered (TCR) Immunotherapy for Treatment of Liver Cancer. |
|
|
Aug 31, 2018 |
475 |
| AstraZeneca reports Phase 3 anifrolumab trial did not meet primary endpoint. |
|
|
Aug 31, 2018 |
137 |
| Arrowhead completes dosing in Phase 1 study of ARO-AAT. |
|
|
Aug 31, 2018 |
156 |
| United States : Update on TULIP 1 Phase III trial for anifrolumab in systemic lupus erythematosus. |
|
|
Aug 31, 2018 |
181 |
| Pfizer Terminates Domagrozumab Clinical Studies for the Treatment of Duchenne Muscular Dystrophy. |
|
Clinical report |
Aug 31, 2018 |
563 |
| Eagle Pharmaceuticals Concludes Enrollment of Second Safety and Efficacy Study at Hajj to Evaluate Ryanodex for Exertional Heat Stroke. |
|
Clinical report |
Aug 31, 2018 |
688 |
| Sophiris Bio provides update of Phase 2b localised prostate cancer trial. |
|
|
Aug 30, 2018 |
262 |
| Eagle Pharmaceuticals concludes enrollment of second Ryanodex study. |
|
Clinical report |
Aug 30, 2018 |
267 |
| Pfizer terminates domagrozumab clinical studies for the treatment of DMD. |
|
Clinical report |
Aug 30, 2018 |
304 |
| First Subject Dosed In Phase 1 Trial Evaluating INP105 for the Treatment Of Acute Agitation In Bipolar I Disorder And Schizophrenia. |
|
|
Aug 30, 2018 |
616 |
| Sophiris Bio Updates on Phase 2b Localized Prostate Cancer Trial Following Patient Death. |
|
|
Aug 30, 2018 |
599 |
| Tenax Therapeutics: New Clinical Study Publication Results Indicate Levosimendan Offers Renal Protective Benefits to Heart Failure Patients. |
|
Clinical report |
Aug 29, 2018 |
476 |
| Arena reports presentation of Phase 1 clinical data for ralinepag. |
|
|
Aug 28, 2018 |
103 |
| Esperion announces Phase 3 bempedoic acid/ezetimibe study meets endpoints. |
|
Clinical report |
Aug 27, 2018 |
310 |
| FDA Grants Fast Track Designation for Phase 3 Trial of Inhaled Xenon Gas Therapy. |
|
|
Aug 27, 2018 |
469 |
| Roche receives FDA Approval for Cobas EGFR Mutation Test v2 as Companion Diagnostic with Iressa in First-Line Treatment of Patients with Non-Small Cell Lung Cancer. |
|
|
Aug 27, 2018 |
378 |
| The Grant Will Support Operations And Phase 2a Development Of Avid100, A Highly Potent Anti-egfr Antibody-drug Conjugate. |
|
|
Aug 25, 2018 |
446 |
| Laser treatment trial could help cancer sufferers. |
|
|
Aug 25, 2018 |
653 |
| AstraZeneca provides update on AERISTO Phase IIIb trial for Bevespi Aerosphere in chronic obstructive pulmonary disease. |
|
|
Aug 24, 2018 |
216 |
| FDA grants fast track designation to Mallinckrodt and NPXe's phase 3 trial of inhaled xenon gas therapy. |
|
|
Aug 24, 2018 |
246 |
| AstraZeneca reports top-line results from AERISTO phase IIIb trial for Bevespi Aerosphere in COPD. |
|
|
Aug 24, 2018 |
260 |
| AstraZeneca provides update on AERISTO Phase IIIb trial for Bevespi Aerosphere in chronic obstructive pulmonary disease. |
|
|
Aug 24, 2018 |
212 |
| FDA grants fast track designation to Mallinckrodt and NPXe's phase 3 trial of inhaled xenon gas therapy. |
|
|
Aug 24, 2018 |
242 |
| Mallinckrodt & NPXe partnership passes US FDA's Fast Track Designation for Phase 3 trial of inhaled xenon gas therapy. |
|
|
Aug 24, 2018 |
267 |
| Mallinckrodt & NPXe partnership passes US FDA's Fast Track Designation for Phase 3 trial of inhaled xenon gas therapy. |
|
|
Aug 24, 2018 |
263 |
| Pfizer, Astellas Amend Clinical Research Protocols for Two Phase 3 Trials of Enzalutamide in Patients with Hormone-Sensitive Prostate Cancer. |
|
Clinical report |
Aug 24, 2018 |
296 |
| Service Contract - Search For Expert Trainers For Specific Training In Clinical Studies. |
|
Clinical report |
Aug 24, 2018 |
102 |
| Novaremed Has Raised CHF 6m to Prepare for a Phase 2b Clinical Study in Diabetic Neuropathic Pain. |
|
Clinical report |
Aug 24, 2018 |
361 |
| AstraZeneca reports top-line results from AERISTO phase IIIb trial for Bevespi Aerosphere in COPD. |
|
|
Aug 24, 2018 |
264 |
| Kala Pharmaceuticals announces FDA approval of Inveltys. |
|
|
Aug 23, 2018 |
129 |
| Imago BioSciences Completes Enrollment in Phase 1/2a Study of IMG-7289 in Acute Myeloid Leukemia and Myelodysplastic Syndrome. |
|
Report |
Aug 23, 2018 |
320 |
| COMPASS to begin Psilocybin Therapy clinical trial in patients with treatment-resistant depression following the US FDA approval. |
|
|
Aug 23, 2018 |
202 |
| Merck signs clinical trial collaboration agreement with Rexahn Pharmaceuticals. |
|
|
Aug 23, 2018 |
181 |
| Can-Fite BioPharma enrols and doses first patient in phase three Piclidenoson Comfort trial. |
|
|
Aug 23, 2018 |
165 |
| ALK-Abello announces acceptance of review of its registration application for tree SLIT-tablet in Europe. |
|
Brief article |
Aug 23, 2018 |
281 |
| COMPASS to begin Psilocybin Therapy clinical trial in patients with treatment-resistant depression following the US FDA approval. |
|
|
Aug 23, 2018 |
198 |
| Merck signs clinical trial collaboration agreement with Rexahn Pharmaceuticals. |
|
|
Aug 23, 2018 |
177 |
| Can-Fite BioPharma enrols and doses first patient in phase three Piclidenoson Comfort trial. |
|
|
Aug 23, 2018 |
161 |
| Pfizer, Astellas amend clinical research protocols for two Phase 3 enzalutamide trials. |
|
|
Aug 23, 2018 |
254 |
| Pfizer, Astellas amend clinical research protocols for two Phase 3 enzalutamide trials. |
|
|
Aug 23, 2018 |
250 |
| Sensorion to commence phase two trial of SENS-401. |
|
|
Aug 22, 2018 |
169 |
| Sensorion to commence phase two trial of SENS-401. |
|
|
Aug 22, 2018 |
165 |
| Veristat Congratulates Alnylam on the FDA Approval of Onpattro. |
|
|
Aug 22, 2018 |
252 |
| Pfizer, Astellas amend clinical research protocols for two phase 3 trials. |
|
Clinical report |
Aug 22, 2018 |
227 |
| MC2 Therapeutics Touts Positive Top-line Results from Phase 3 Clinical Trial Comparing MC2-01 Cream to Taclonex in Adults with Psoriasis. |
|
|
Aug 22, 2018 |
567 |
| Wishaw man's drug trial blow; Ged refused new MND treatment. |
|
|
Aug 22, 2018 |
472 |
| Biosceptre reports launch of Phase 1 clinical trial of first-in-class oncology vaccine BIL06v. |
|
|
Aug 22, 2018 |
288 |
| Biosceptre reports launch of Phase 1 clinical trial of first-in-class oncology vaccine BIL06v. |
|
|
Aug 22, 2018 |
284 |
| Vitamin D on glycaemia control in type 2 diabetes patients: A systematic review of randomised clinical trials. |
Yu, Xue Fei; Zaslawaki, Christopher; Lim, Chi Eung Danforn |
|
Aug 22, 2018 |
7323 |
| The effectiveness of manual lymphatic drainage and low level laser in the treatment of a client with lipedema: an N-of-1 trial. |
Balinski, Angela; Grace, Sandra; Avila, Cathy; Bradbury, Jo |
|
Aug 22, 2018 |
1462 |
| AbbVie signs clinical research collaboration with Tolero Pharmaceuticals. |
|
|
Aug 21, 2018 |
200 |
| Viela Bio begins first clinical trial of VIB9600 in healthy adult volunteers. |
|
|
Aug 21, 2018 |
186 |
| AbbVie signs clinical research collaboration with Tolero Pharmaceuticals. |
|
|
Aug 21, 2018 |
196 |
| Viela Bio begins first clinical trial of VIB9600 in healthy adult volunteers. |
|
|
Aug 21, 2018 |
182 |
| Xeris Pharmaceuticals, OHSU Conducting Artificial Pancreas Clinical Trial Using Xeris' Novel Ready-to-Use Liquid Glucagon. |
|
|
Aug 21, 2018 |
643 |
| Tolero Pharmaceuticals Forges Clinical Research Collaboration with AbbVie for Acute Myeloid Leukemia Trial. |
|
|
Aug 21, 2018 |
483 |
| Singapore's Health Sciences Authority approves Lion TCR's Phase I/II multicentre clinical study of LioCyx. |
|
|
Aug 20, 2018 |
169 |
| Tolero Pharmaceuticals signs clinical research collaboration with AbbVie. |
|
|
Aug 20, 2018 |
171 |
| Lion TCR Pte Ltd approves first clinical trial for T cell engineered (TCR) immunotherapy in Singapore for treatment of liver cancer. |
|
|
Aug 20, 2018 |
284 |
| Singapore's Health Sciences Authority approves Lion TCR's Phase I/II multicentre clinical study of LioCyx. |
|
|
Aug 20, 2018 |
173 |
| Lion TCR Pte Ltd approves first clinical trial for T cell engineered (TCR) immunotherapy in Singapore for treatment of liver cancer. |
|
|
Aug 20, 2018 |
288 |
| Tolero Pharmaceuticals signs clinical research collaboration with AbbVie. |
|
|
Aug 20, 2018 |
175 |
| Viela Bio begins clinical trials months after $250M spinoff. |
|
|
Aug 20, 2018 |
444 |
| Trovagene Completes Second Dosing Cohort of Patients Treated with Onvansertib in Ongoing Phase 1b/2 AML Trial. |
|
|
Aug 17, 2018 |
859 |
| Biohaven Reports Positive Results from Double-Blind, Placebo-Controlled, Investigator Initiated, Proof Of Concept Trial Of BHV-0223 For Anxiety. |
|
Financial report |
Aug 17, 2018 |
745 |
| Agenus Receives Second Milestone Payment from Merck as Phase I Clinical Trial Launches. |
|
|
Aug 17, 2018 |
242 |
| Abeona reports draft version of EB-101 Phase 3 trial protocol posted prematurely. |
|
Clinical report |
Aug 17, 2018 |
108 |
| Xeris Pharmaceuticals, OHSU conduct artificial pancreas clinical trial. |
|
|
Aug 17, 2018 |
228 |
| Inovio Pharmaceuticals commences PENNVAX-GP randomised clinical trial. |
|
|
Aug 16, 2018 |
273 |
| Inovio Pharmaceuticals commences PENNVAX-GP randomised clinical trial. |
|
|
Aug 16, 2018 |
269 |
| Biohaven says BHV-0223 proof of concept clinical trial met primary endpoint. |
|
|
Aug 16, 2018 |
305 |
| Clementia Pharmaceuticals completes enrollment in Phase 3 MOVE Trial for FOP. |
|
|
Aug 16, 2018 |
126 |
| Regeneron, Teva announce 'positive' topline Phase 3 fasinumab results. |
|
Clinical report |
Aug 16, 2018 |
211 |
| Trovagene completes second dosing of Phase 1b/2 trial of AML candidate. |
|
|
Aug 16, 2018 |
155 |
| Iovance Biotherapeutics announces clinical trial updates with collaborators. |
|
|
Aug 16, 2018 |
151 |
| Oragenics resumes Phase 2 clinical trial of AG013. |
|
|
Aug 15, 2018 |
305 |
| CEL-SCI says IDMC recommends continuation of Phase 3 head and neck cancer study. |
|
|
Aug 15, 2018 |
136 |
| Izana Bioscience Initiates Namilumab Phase II Proof-of-Concept Clinical Study in Ankylosing Spondylitis. |
|
Clinical report |
Aug 15, 2018 |
333 |
| Izana Bioscience commenced phase II proof-of-concept clinical study of ankylosing spondylitis drug namilumab. |
|
Clinical report |
Aug 15, 2018 |
163 |
| Izana Bioscience commenced phase II proof-of-concept clinical study of ankylosing spondylitis drug namilumab. |
|
Clinical report |
Aug 15, 2018 |
159 |
| Samsung Bioepis to Initiate Phase 1 Clinical Trial of SB26 Ulinastatin-Fc Fusion Protein. |
|
|
Aug 14, 2018 |
257 |
| Realm Therapeutics reports preliminary data from Phase 2 trial of PR022. |
|
|
Aug 14, 2018 |
142 |
| Aveo announces acceptance of CANbridge IND application for CAN017 trial. |
|
|
Aug 14, 2018 |
121 |
| Electromed 'thrilled' by results of independent clinical study. |
|
Clinical report |
Aug 14, 2018 |
149 |
| Orphazyme reports enrolment of first patient in phase III clinical trial of arimoclomol for ALS. |
|
|
Aug 13, 2018 |
246 |
| Orphazyme reports enrolment of first patient in phase III clinical trial of arimoclomol for ALS. |
|
|
Aug 13, 2018 |
242 |
| Celltrion Enters into Phases 1 and 3 Clinical Trials for the Adalimumab Biosimilar 'CT-P17'. |
|
|
Aug 13, 2018 |
302 |
| Checkpoint says clinical data on CK-101 selected for presentation at IASLC. |
|
|
Aug 13, 2018 |
172 |
| Unum Therapeutics announces IND activation for ACTR T cells with trastuzumab. |
|
|
Aug 13, 2018 |
124 |
| United States : Sesen Bio Announces Vicinium Granted Fast Track Designation by FDA for Treatment of Non-muscle Invasive Bladder Cancer. |
|
|
Aug 13, 2018 |
299 |
| Phase 2 Clinical Trial Of Ischemic Stroke Therapy Launched In China. |
|
Clinical report |
Aug 13, 2018 |
205 |
| First Patient In Phase 3 Study Of Multistem Treatment For Ischemic Stroke. |
|
|
Aug 13, 2018 |
496 |
| Twelve-Month Update For Clinical Trial In Severe SCI. |
|
|
Aug 13, 2018 |
237 |
| Sweden : Investigator-initiated phase II clinical study of remetinostat started in patients with basal cell carcinoma. |
|
Report |
Aug 9, 2018 |
199 |
| First Patient Dosed with AMC303 in Phase Ib Extension Cohort Based on Positive Safety Results. |
|
|
Aug 8, 2018 |
426 |
| Sangamo's candidate for Hemophilia A shows positive Phase 1/2 safety data. |
|
|
Aug 8, 2018 |
154 |
| AnaptysBio expects to report Phase 2a asthma data in Q3. |
|
Clinical report |
Aug 7, 2018 |
125 |
| BioLineRx says 'extremely encouraged' by lead-in period of Phase 3 GENESIS trial. |
|
|
Aug 7, 2018 |
296 |
| Madrigal sees 'high likelihood of success' for Phase 3 MGL-3196 study. |
|
|
Aug 7, 2018 |
167 |
| TG Therapeutics completes target enrollment in ULTIMATE Phase 3 Trials in MS. |
|
|
Aug 7, 2018 |
106 |
| Viveve announces FDA approval to continue VIVEVE II clinical study. |
|
|
Aug 7, 2018 |
157 |
| Bellerophon says DMC recommends stopping Phase 3 INOvation-1 study of INOpulse. |
|
|
Aug 7, 2018 |
384 |
| u.s cancer trial is ellen's dream; Mum Claire pins hopes for brave tot, 3, on clinical research bid. |
|
|
Aug 7, 2018 |
708 |
| United Kingdom : Clinical Trials Regulation. |
|
|
Aug 7, 2018 |
942 |
| Ovid Therapeutics says Phase 2 STARS Trial of OV101 achieved primary endpoint. |
|
Clinical report |
Aug 6, 2018 |
583 |
| Phase 2 Clinical Trial Of The hemic St unched In China. |
|
Clinical report |
Aug 6, 2018 |
205 |
| First Patient: In Phase 3 Study Of Multistem Treatment For Ischemic Stroke. |
|
|
Aug 6, 2018 |
496 |
| Twelve-Month Update For Asterias' Clinical Trial In Severe SCI. |
|
|
Aug 6, 2018 |
237 |
| Phase 2 Clinical Trial Of Ischemic Stroke Therapy Launched In China. |
|
Clinical report |
Aug 6, 2018 |
205 |
| First Patient: In Phase 3 Study Of Multistem Treatment For Ischemic Stroke. |
|
|
Aug 6, 2018 |
496 |
| Twelve-Month Update For Asterias' Clinical Trial In Severe SCI. |
|
|
Aug 6, 2018 |
237 |
| Clinical Research of Pulmonary Langerhans Cell Histiocytosis in Children. |
Wang, Dong; Cui, Lei; Li, Zhi-Gang; Zhang, Li; Lian, Hong-Yun; Ma, Hong-Hao; Zhao, Yun-Ze; Zhao, Xia |
Report |
Aug 5, 2018 |
3683 |
| Marken opens new Melbourne clinical trial logistics hub. |
|
|
Aug 3, 2018 |
143 |
| Marken opens new Melbourne clinical trial logistics hub. |
|
|
Aug 3, 2018 |
139 |
| Bonti Announces Completion of Phase 2a Scar Reduction Clinical Study. |
|
Clinical report |
Aug 3, 2018 |
543 |
| CalciMedica treats first patients with CM4620 in acute pancreatitis clinical study. |
|
Clinical report |
Aug 2, 2018 |
204 |
| Nicox begins Phase 2 study of NCX 470 in open-angle glaucoma and ocular hypertension. |
|
|
Aug 2, 2018 |
230 |
| CalciMedica treats first patients with CM4620 in acute pancreatitis clinical study. |
|
Clinical report |
Aug 2, 2018 |
200 |
| Nicox begins Phase 2 study of NCX 470 in open-angle glaucoma and ocular hypertension. |
|
|
Aug 2, 2018 |
226 |
| Emergent BioSolutions starts phase one clinical study to assess ZIKV-IG. |
|
|
Aug 2, 2018 |
148 |
| Emergent BioSolutions starts phase one clinical study to assess ZIKV-IG. |
|
|
Aug 2, 2018 |
144 |
| Takeda Touts New Phase 3 Data on Investigational Subcutaneous Formulation of Vedolizumab in Moderately to Severely Active Ulcerative Colitis. |
|
|
Aug 2, 2018 |
311 |
| New England Journal of Medicine has Publishes Emmaus Life Sciences Endari Phase 3 Trial Results. |
|
|
Aug 2, 2018 |
715 |
| Bristol-Myers Squibb, Gritstone Oncology Forge Clinical Research Collaboration to Evaluate Novel Immunotherapy Approach in Advanced Solid Tumors. |
|
|
Aug 2, 2018 |
610 |
| Spring Bank Pharmaceuticals announces 'positive' results from Phase 2 ACHIEVE. |
|
Financial report |
Aug 2, 2018 |
456 |
| United States : Governor Wolf Announces New Apprenticeships for Clinical Research, Residential Electricians. |
|
|
Aug 2, 2018 |
521 |
| Theravance Biopharma reports 'positive' data from Phase 2 trial of TD-9855. |
|
|
Aug 1, 2018 |
218 |
| BioLineRx initiates Phase 1/2a clinical study for AGI-134. |
|
Clinical report |
Aug 1, 2018 |
179 |
| Denali announces 'positive' clinical results from Phase 1 DNL201 study. |
|
Report |
Aug 1, 2018 |
234 |
| From Randomized Controlled Trials to the Real World: Putting Evidence into Context. |
Blonde, Lawrence; Dendy, Jared A.; Skolnik, Neil; White, John R. |
Clinical report |
Aug 1, 2018 |
4715 |
| The Economic Impact of Clinical Research in an Italian Public Hospital: The Malignant Pleural Mesothelioma Case Study. |
Ippoliti, Roberto; Falavigna, Greta; Grosso, Federica; Maconi, Antonio; Randi, Lorenza; Numico, Gian |
|
Aug 1, 2018 |
8007 |
| Development and Pre-clinical Study of Anti-Allergic Cream Containing Dexamethasone and Chlorpheniramine/Deksametazon ve Klorfeniramin Iceren Anti-alerjik Kremlerin Gelistirilmesi ve Klinik Oncesi Calismasi. |
Pham, Duy Toan; Nguyen, Ngoc Nha Thao |
Clinical report |
Aug 1, 2018 |
3816 |
| Comparative Clinical Study of the Effectiveness of MEKRITEN in Patients with Chronic Suppurative Otitis/Kronik Supuratif Otitis Mediali Hastalarda MEKRITEN Etkinliginin Karsilastirmali Klinik Calismasi. |
Mukhitdinov, Abror; Olimov, Nemat; Olimova, Shirinkhan |
Clinical report |
Aug 1, 2018 |
3493 |
| A Randomized Trial of Off-Site Collaborative Care for Depression in Chronic Hepatitis C Virus. |
Kanwal, Fasiha; Pyne, Jeffrey M.; Tavakoli-Tabasi, Shahriar; Nicholson, Susan; Dieckgraefe, Brian; S |
Clinical report |
Aug 1, 2018 |
7131 |
| Estimation of Population Average Treatment Effects in the FIRST Trial: Application of a Propensity Score-Based Stratification Approach. |
Chung, Jeanette W.; Bilimoria, Karl Y.; Stulberg, Jonah J.; Quinn, Christopher M.; Hedges, Larry V. |
Report |
Aug 1, 2018 |
8356 |
| Verona Pharma begins Phase 2 clinical trial evaluating nebulised RPL554 as add-on therapy. |
|
|
Aug 1, 2018 |
232 |
| Verona Pharma begins Phase 2 clinical trial evaluating nebulised RPL554 as add-on therapy. |
|
|
Aug 1, 2018 |
228 |
| GE Healthcare, Lantheus Start Phase 3 Clinical Trial of Investigational Agent for the Detection of Coronary Artery Disease. |
|
|
Aug 1, 2018 |
438 |
| 180 Therapeutics Touts Positive Results from a Phase 2a Clinical Trial of Anti-TNF Therapy in Dupuytren's Disease. |
|
|
Aug 1, 2018 |
573 |
| Cerecor enrolls first patient in Phase I trial for nOH in Parkinson's disease. |
|
|
Aug 1, 2018 |
101 |
| Proclara Biosciences Initiates Clinical Trial of NPT189 for Systemic Amyloidoses. |
|
|
Jul 31, 2018 |
175 |
| We were shocked by position of higher education, former health ministers in Clinical Trial Law: MP Mostafa Kamal El-Din Hussein. |
|
|
Jul 31, 2018 |
1751 |
| JHL Biotech Receives Positive CHMP Scientific Advice for Global Phase III Clinical Trial of Proposed Rituximab Biosimilar. |
|
|
Jul 31, 2018 |
278 |
| JHL Biotech Announces China Approves Clinical Trial Rituximab Biosimilar to Treat Non-Hodgkin Lymphoma. |
|
|
Jul 31, 2018 |
276 |
| The First Successful Uterus Transplantation in the Mena Region Under Clinical Research. |
|
|
Jul 31, 2018 |
365 |
| Lantheus, GE Healthcare start Phase 3 trial of Flurpiridaz F. |
|
|
Jul 31, 2018 |
200 |
| ARCA Biopharma announces 'positive' outcome of End-of-Phase 2 meeting with FDA. |
|
|
Jul 31, 2018 |
388 |
| Clinical Research Organization For Study going. |
|
|
Jul 31, 2018 |
113 |
| Source Strengthning And Pump House Raw Water Rising Main Raw Water Pumping Machinery Water Treatment Plant Pure Water Rising Main Pure Water Pumping Machinery Rcc Esr Distribution System Trial Run And. |
|
|
Jul 30, 2018 |
193 |
| A CLINICAL STUDY ON HIV-TB CO-INFECTION. |
Mathew, Sheela; Sandeep |
Report |
Jul 30, 2018 |
3813 |
| First U.S. Patients Treated In Phase 2 CLI Trial. |
|
|
Jul 30, 2018 |
256 |
| Clinical Research Organization (cro) Per Estudi Going "regorafenib Followed By Nicolumab In Patients With Hepatocellullar Carcinoma Progressin Under Sorafenib". |
|
|
Jul 29, 2018 |
133 |
| United States : PPD Expands Central Labs Preclarus Technology, Helping Clients Accelerate and Enhance Clinical Research Decision-making. |
|
|
Jul 28, 2018 |
411 |
| Medivir sees positive results from MIV-711 Phase IIa extension study. |
|
|
Jul 27, 2018 |
255 |
| Medivir sees positive results from MIV-711 Phase IIa extension study. |
|
|
Jul 27, 2018 |
251 |
| Eton Pharma's Phase III Trial of EM-100 Ophthalmic Solution Yields Positive Results. |
|
|
Jul 27, 2018 |
160 |
| Sandoz receives European Commission approval for biosimilar Hyrimoz. |
|
|
Jul 27, 2018 |
133 |
| Germany : Bayer receives approval for Kovaltry in China for the treatment of children and adults with Hemophilia A. |
|
|
Jul 27, 2018 |
155 |
| Japan : Eisai and Biogen Announce Detailed Results of Phase Ii Clinical Study of Ban2401 in Early Alzheimers Disease at Alzheimers Association International Conference (Aaic) 2018. |
|
Conference news |
Jul 27, 2018 |
473 |
| Japan : Eisai and Biogen Present Detailed Results From Phase Ii Clinical Study of Elenbecestat in Mci and Mild to Moderate Alzheimers Disease at Alzheimers Association International Conference (Aaic) 2018. |
|
Conference news |
Jul 27, 2018 |
717 |
| Destiny Pharma reports positive data from Phase 1 skin irritation study. |
|
|
Jul 26, 2018 |
222 |
| Destiny Pharma reports positive data from Phase 1 skin irritation study. |
|
|
Jul 26, 2018 |
218 |
| Eisai and Biogen Present Detailed Results from Phase II Clinical Study of Elenbecestat in MCI and Mild to Moderate Alzheimer's Disease at AAIC 2018. |
|
Clinical report |
Jul 26, 2018 |
1582 |
| Eisai and Biogen Announce Detailed Results of Phase II Clinical Study of BAN2401 in Early Alzheimer's Disease at AAIC 2018. |
|
Clinical report |
Jul 26, 2018 |
2217 |
| US FDA Grants Approval of Orilissa (elagolix) for Management of Moderate to Severe Pain Associated with Endometriosis. |
|
|
Jul 26, 2018 |
231 |
| Aldeyra Therapeutics Enrolls First Patient in Phase 3 Clinical Trial of Reproxalap for Treatment of Ichthyosis in SjA[pilcrow sign]gren-Larsson Syndrome. |
|
|
Jul 26, 2018 |
312 |
| United States : NIH-funded researchers present preliminary clinical trial results suggesting aggressive blood pressure control may lower risk of cognitive impairment. |
|
|
Jul 26, 2018 |
253 |
| NeuroVia begins Phase 1/2 clinical study of lead drug candidate NV1205 for childhood cerebral adrenoleukodystrophy treatment. |
|
|
Jul 25, 2018 |
305 |
| NeuroVia begins Phase 1/2 clinical study of lead drug candidate NV1205 for childhood cerebral adrenoleukodystrophy treatment. |
|
|
Jul 25, 2018 |
301 |
| Merck says Phase 3 KEYNOTE-048 trial met a primary endpoint. |
|
|
Jul 25, 2018 |
184 |
| Merck: Phase 3 KEYNOTE-048 trial met primary endpoint of OS. |
|
|
Jul 25, 2018 |
175 |
| ResTORbio announces 'positive' topline results in Phase 2b trial of RTB101. |
|
|
Jul 25, 2018 |
609 |
| Cerprobe to commence Phase 3 study of lenabasum. |
|
Clinical report |
Jul 25, 2018 |
194 |
| Biogen announces detailed results from Phase 2 study of elenbecestat. |
|
Clinical report |
Jul 25, 2018 |
411 |
| Reagents, Control And Expendable Materials For Analyzers Of The Clinical Diagnostic Laboratory, Diagnostic Kits For General Clinical Research Of The Health Care Institution 4th City Childrens Clinical. |
|
|
Jul 25, 2018 |
171 |
| Tonsillectomy pain control with IV dexamethasone, infiltrated dexamethasone and infiltrated bupivacaine; a randomised, double-blind, placebo controlled, prospective clinical trial. |
|
|
Jul 25, 2018 |
2700 |
| SHORT COMMUNICATION - Clinical Trial Registry: An essential requirement for physical therapy and health researchers in Pakistan. |
|
Clinical report |
Jul 25, 2018 |
3788 |
| Clinical Trial Registry in Pakistan. |
|
|
Jul 25, 2018 |
499 |
| BeiGene starts Phase 3 trial for advanced gastric cancer. |
|
|
Jul 24, 2018 |
236 |
| BeiGene starts Phase 3 trial for advanced gastric cancer. |
|
|
Jul 24, 2018 |
232 |
| Omeros Doses First Cohort in Clinical Trial of Phosphodiesterase 7 Inhibitor Targeting Addiction. |
|
|
Jul 24, 2018 |
218 |
| NEJM Publishes Results of Emmaus Life Sciences Phase 3 Trial of Endari in Sickle Cell Disease. |
|
|
Jul 24, 2018 |
334 |
| Merck announces results from Phase 3 Drive-Forward clinical trial. |
|
Financial report |
Jul 24, 2018 |
117 |
| BeiGene announces first patient dosed in Phase 3 trial of tislelizumab. |
|
|
Jul 24, 2018 |
109 |
| United States : NIH expands program that conducts large-scale clinical trials in real-world settings. |
|
|
Jul 24, 2018 |
782 |
| United States : NIH renews NeuroNEXT for neurological clinical research. |
|
|
Jul 24, 2018 |
346 |
| United States : Sangamo Announces Treatment Of First Patient In Phase 1/2 Clinical Trial Evaluating SB-318 Investigational In Vivo Genome Editing Therapy For MPS I. |
|
|
Jul 24, 2018 |
468 |
| Phase 3 Renal Outcomes Trial of Invokana Stopped Early Based on Positive Efficacy. |
|
|
Jul 23, 2018 |
320 |
| Blade Therapeutics Commences Phase 1 Study of Calpain Inhibitor for Fibrosis. |
|
|
Jul 23, 2018 |
200 |
| Acceleron reports preliminary results from Part 1 of ACE-083 Phase 2 trial. |
|
Financial report |
Jul 23, 2018 |
191 |
| Celgene announces phase 3 combined Revlimid-Rituximab study. |
|
Clinical report |
Jul 23, 2018 |
149 |
| First U.S. Patients Treated In Phase 2 CLI Trial. |
|
|
Jul 23, 2018 |
256 |
| First U.S. Patients Treated In Phase 2 CLI Trial. |
|
|
Jul 23, 2018 |
257 |
| Provision Of Experimental Drugs For The Double-blind Apis Clinical Trial Promoted By Public Assistance - Paris Hospitals (ap-hp). |
|
|
Jul 20, 2018 |
131 |
| Sellas Life Sciences receives Fast Track designation for galinpepimut-S. |
|
|
Jul 20, 2018 |
182 |
| Alligator Bioscience submits CTA application to start clinical phase I study in cancer patients with ATOR-1015. |
|
Report |
Jul 20, 2018 |
278 |
| Alligator Bioscience files application for clinical phase I study of ATOR-1015 in cancer patients. |
|
|
Jul 20, 2018 |
216 |
| Alligator Bioscience submits CTA application to start clinical phase I study in cancer patients with ATOR-1015. |
|
Report |
Jul 20, 2018 |
279 |
| Alligator Bioscience files application for clinical phase I study of ATOR-1015 in cancer patients. |
|
|
Jul 20, 2018 |
217 |
| Alligator Bioscience submits CTA application to start clinical phase I study in cancer patients with ATOR-1015. |
|
Report |
Jul 20, 2018 |
274 |
| Alligator Bioscience files application for clinical phase I study of ATOR-1015 in cancer patients. |
|
|
Jul 20, 2018 |
212 |
| Pulmatrix Releases Preliminary Results from Clinical Trial of Pulmazole in Subjects with Asthma. |
|
|
Jul 20, 2018 |
352 |
| SOM Biotech Commences Phase 2a Clinical Trial of SOM3355 in Huntington's Disease. |
|
|
Jul 20, 2018 |
366 |
| PainReform wins US FDA's approval for Phase III post-operative pain relief study of PRF-110. |
|
|
Jul 19, 2018 |
199 |
| PainReform wins US FDA's approval for Phase III post-operative pain relief study of PRF-110. |
|
|
Jul 19, 2018 |
195 |
| PainReform to conduct two pivotal Phase III clinical trials for post-operative pain relief after FDA approval. |
|
|
Jul 19, 2018 |
161 |
| PainReform to conduct two pivotal Phase III clinical trials for post-operative pain relief after FDA approval. |
|
|
Jul 19, 2018 |
157 |
| Allergan and Molecular Partners report 'positive' Phase 3 results for Abicipar. |
|
|
Jul 19, 2018 |
166 |
| Cara Therapeutics doses first patient in Phase 2 trial of Korsuva for pruritus. |
|
|
Jul 19, 2018 |
173 |
| Medtronic starts enrollment in trial for ECG Belt for heart failure therapy. |
|
|
Jul 19, 2018 |
258 |
